Chemopreventive effect of dayak onion [Eleutherine bulbosa, Mill. (Urb)] against 7,12-dimethylbenz [α] anthracene (DMBA)-induced breast cancer in rats: study on cancer antigen 15-3 (CA 15-3)

  • Deo Gratias Efrem Faculty of Medicine, Tanjungpura University, West Kalimantan
  • Muhammad In'am Ilmiawan Departement of Biology and Pathobiology, Faculty of Medicine, Tanjungpura University, West Kalimantan https://orcid.org/0000-0002-9727-626X
  • Sari Eka Pratiwi Departement of Biology and Pathobiology, Faculty of Medicine, Tanjungpura University, West Kalimantan https://orcid.org/0000-0003-4577-8863
Keywords: 7,12-dimethylbenz [α] anthracene, breast cancer, ca 15-3, Eleutherine bulbosa, Mill. (Urb), rat

Abstract

Dayak onion [Eleutherine bulbosa, Mill. (Urb)] is herbal plant believed to have anticancer effects. It contains triterpenoids, flavonoids, anthraquinones, and naphthoquinones which have antioxidants and anticancer activities. This study aimed to investigate the effect of ethanolic extract of dayak onion bulb (EEDO) on serum cancer antigen 15-3 (CA 15-3) levels in rats induced with 7,12-dimethylbenz [a] anthracene (DMBA). Thirty female Sprague Dawley rats were randomly divided into six groups, namely Normal Group, Positive Control Group (tamoxifen), Negative Control Group (dimethyl sulfoxide/DMSO) 5%), Treatment Group I (EEDO 180 mg/kgBW), Treatment Group II (EEDO 360 mg/kgBW) and Treatment Group III (EEDO 720 mg/kgBW). All groups, except the normal group, were induced with DMBA 20 mg/kg body weight. Serum CA 15-3 levels were determined using enzyme-linked immunosorbent assay (ELISA) method. The results showed significantly lower (p< 0.05) CA 15-3 levels in the Treatment Groups compared to the Negative Control Group. The most significant reduction in serum CA 15-3 level was observed in the Treatment Group I receiving  EEDO at a dose of 180 mg/kgBW. In conclusion, the EEDO possesses a chemopreventive effect on DMBA-induced breast cancer in rats.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6):394-424.

htps://doi.org/10.3322/caac.21492

Nath S, Mukherjee P. Muc1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 2014; 20(6):332-42.

https://doi.org/10.1016/j.molmed.2014.02.007

Li X, Dai D, Chen B, Tang H, Xie X, Wei W. Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer. Oncol Lett 2018; 16(4):4679-88.

https://doi.org/10.3892/ol.2018.9160

Di Gioia D, Dresse M, Mayr D, Nagel D, Heinemann V, Stieber P. Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer. Clin Chim Acta 2015; 440:16-22.

https://doi.org/10.1016/j.cca.2014.11.001

Nandhakumar R, Salini K, Niranjali Devaraj S. Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis. Mol Cell Biochem 2012; 364(1-2):79-92.

https://doi.org/10.1007/s11010-011-1207-5

Kwon YJ, Ye DJ, Baek HS, Chun YJ. 7,12-Dimethylbenz[α]anthracene increases cell proliferation and invasion through induction of WNT/β-catenin signaling and EMT process. Environ Toxicol 2018; 33(7):729-42.

https://doi.org/10.1002/tox.22560

Nassan MA, Soliman MM, Ismail SA, El-Shazly S. Effect of Taraxacum officinale extract on PI3K/Akt pathway in DMBA-induced breast cancer in Albino rats. Biosci Rep 2018; 38(6):BSR20180334.

https://doi.org/10.1042/BSR20180334

Alvarado A, Lopes AC, Faustino-Rocha AI, Cabrita AMS, Ferreira R, Oliveira PA, et al. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats. Pathol Res Pract 2017; 213(5):441-6.

https://doi.org/10.1016/j.prp.2017.02.014

Gu KJ, Li G. An overview of cancer prevention: chemoprevention and immunoprevention. J Cancer Prev 2020; 25(3):127-35.

https://doi.org/10.15430/JCP.2020.25.3.127

Kodama M, Kodama T. The nature of tamoxifen action in the control of female breast cancer. In Vivo, 2001;15(4):319-25. PMID: 11695224.

Insanu M, Kusmardiyani S, Hartati R. Recent studies on phytochemicals and pharmacological effects of Eleutherine americana Merr. Procedia Chem 2014; 13:221-8.

https://doi.org/10.1016/j.proche.2014.12.032

Paramita S, Nuryanto MK. Anti-inflammatory activity of bawang dayak (Eleutherine bulbosa (Mill. Urb.)) ethanol bulb extracts. J Vocat Health Stud 2019; 2(2):51-5.

https://doi.10.20473/jvhs.V2.I2.2018.51-55

Lubis IA, Ichwan MF, Mustofa M, Satria D. Anticancer activity of Eleutherine bulbosa (Mill.) Urb. extract on WIDR cell line in vitro. Atlantis Press 2017.

https://doi.org/10.2991/phico-17.2018.25

Bahtiar A, Annisa R. Effects of dayak onion bulbs (Eleutherine bulbosa (Mill.) Urb) on bone development of the hipoestrogen model rat. Pharmacog J 2018; 10(2):299-303.

https://doi.org/10.5530/pj.2018.2.52

Jiang H, Man WJ, Hou AJ, Yang L, Xing XD, Yan ML, et al. The chemical constituents from the active fractions of Eleutherine bulbosa with their antimicrobial activity. Nat Prod Res 2020; 34(12):1743-49.

https://doi.org/10.1080/14786419.2018.1530229

Daryono BS, Deisshinta W, Sudarsono. Identification of bawang sabrang (Eleutherine americana Merr. ex K. Heyne) in Indonesia based on chromosome characters. Indones J Pharm 2013; 24(1):22-9.

doi:10.14499/indonesianjpharm24iss1pp22-29

Rani V. Isolation of a compound from the bulbs of Eleutherine bulbosa (Miller) Urban (Iridaceae). Asian J Pharm Clin Res 2018; 11(6):406.

https://doi.org/10.22159/ajpcr.2018.v11i6.25059

Fitri Y, Rosidah, Suwarso E. Effects of inhibition cell cycle and apoptosis of sabrang onion extract (Eleutherine bulbosa (Mill.) Urb.) on breast cancer cells. Int J PharmTech Res 2014, 6(4):1392-96.

PubChem. 7,12-Dimethylbenz[a]Anthracene. https://pubchem.ncbi.nlm.nih.gov/ compound/6001

Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 2009; 9:187.

https://doi.org/10.1186/1471-2407-9-187

Rajalakshmi TR, AravindhaBabu N, Shanmugam KT, Masthan KMK. DNA adducts-chemical addons. J Pharm Bioallied Sci 2015; 7(Suppl 1):S197-9.

https://doi.org/10.4103/0975-7406.155901

Lee JS, Park S, Park JM, Cho JH, Kim SI, Park BW. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers. Breast Cancer Res Treat 2013; 141(3):477-84.

https://doi.org/10.1007/s10549-013-2695-7

Sudarmawan IH. Pengaruh pemberian fraksi etanolik dan petroleum eter ekstrak umbi bawang dayak (Eleutherine palmifolia (L), Merr ) terhadap ekspresi p53 mutan galur sel kanker payudara T47D. [PhD Thesis]. Program Pendidikan Dokter Spesialis I Ilmu Bedah Fakultas Kedokteran, Universitas Sebelas Maret; 2009.

Putri ENA, Haryoto. Aktivitas antikanker ekstrak etanol umbi bawang dayak (Eleutherine americana Merr.) terhadap sel kanker payudara T47D. Presiding of The 7th University Research Colloqium 2018STIKES PKU Muhammadiyah Surakarta, 7:192-203.

Muller PAJ, Vousden KH. Mutant p53 in cancer: New functions and therapeutic opportunities. Cancer Cell 2014; 25(3):304-17.

https://doi.org/10.1016/j.ccr.2014.01.021

Perri F, Pisconti S, Scarpati GDV. p53 mutations and cancer: a tight linkage. Ann Transl Med 2016; 4(24):522.

https://doi.org/10.21037/atm.2016.12.40

Brayman M, Thathiah A, Carson DD. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004; 2:4.

https://doi.org/10.1186/1477-7827-2-4

Yang C, Murray JL, Ibrahim NK. MUC-1 and cancer immunotherapy. Immunology 2018; 225-40.

https://doi.org/10.1016/B978-0-12-809819-6.00015-0

Pillai K, Pourgholami MH, Chua TC, Morris DL. MUC1 as a potential target in anticancer therapies. Am J Clin Oncol 2015; 38(1):108-18.

https://doi.org/10.1097/COC.0b013e31828f5a07

Bernier AJ, Zhang J, Lillehoj E, Shaw ARE, Gunasekara N, Hugh JC. Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion. Mol Cancer 2011; 10:93.

https://doi.org/10.1186/1476-4598-10-93

Jing X, Liang H, Hao C, Yang X, Cui X. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep 2019; 41(2):801-10.

https://doi.org/10.3892/or.2018.6887

Apostolopoulos V, Stojanovska L, Gargosky SE. MUC1 (CD227): a multi-tasked molecule. Cell Mol Life Sci 2015; 72(23):4475-500.

https://doi.org/10.1007/s00018-015-2014-z

Published
2024-08-21
Section
Articles